<DOC>
	<DOCNO>NCT01861873</DOCNO>
	<brief_summary>Background : Anatomical ( traditional ) stereotactic body radio therapy ( SBRT ) treatment plan assumes homogenous distribution function normal liver tissue . In functional treatment planning , additional information distribution function derive functional imaging normal tissue take account . functional treatment planning become possible prioritize spare best functioning part organ . Aim : To test whether functional treatment planning base 18-FDGal PET/CT may spare best function liver tissue . Endpoints : Reduction hepatic systemic clearance ( K ) dynamic 18-FDGal PET/CT scan one month SBRT compare baseline status sub-volumes recieving 15 Gy high . Secondly , investigator evaluate toxicity SBRT toxicity score system include biochemical measure well symptomatic score .</brief_summary>
	<brief_title>Functional Treatment Planning Utilizing 18-FDGal PET/CT SBRT Liver Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Performance status &gt; 2 liver metastasis referee SBRT pregnancy claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>liver function</keyword>
	<keyword>galactose</keyword>
	<keyword>18-F-deoxy-galactose</keyword>
</DOC>